Novel technologies for cancer biomarker discovery: Humoral proteomics

Abstract
The repertoires of serum autoantibodies differ between healthy people and cancer patients. While in healthy individuals these autoantibodies are directed against a limited number of self-proteins, in cancer patients the antibody repertoires are much